Dr. Yanagi earned his PhD in Economics at Kyoto University and serves as a visiting professor at the Graduate School of Accountancy, Waseda University. His public service work includes serving on the Tokyo Stock Exchange Listing System Improvement Advisory Committee, as chairman of the Management Finance Course of the Japan Productivity Center's Academy of Management Development. He was also a working group member of the G7 Impact Transparency Task Force 2021 to advise the UK government. Currently he is also an Executive Advisor for Abeam Consulting, advising Japanese corporates on advancing ESG management through his Yanagi Model. In his professional career, he has served as an executive director of UBS Securities, and senior managing executive officer and chief financial officer (CFO) of Eisai Co., one of the largest pharmaceutical companies in Japan. Dr. Yanagi was named the "Best CFO in the Healthcare Sector" in 2016, 2017, 2019, 2020, and 2022 by Institutional Investor magazine's Global Institutional Investor Poll.